Difficulty: Medium
Average Score: 85%
Practice
The non-glycoside positive inotropic drug is:
Correct answer
C
Rationale
In pharmacological lifespan treatment, understanding the differences between various drugs is crucial. In this case, the correct answer is C) Dobutamine, a non-glycoside positive inotropic drug.
Dobutamine works by stimulating beta-1 adrenergic receptors in the heart, leading to increased contractility and heart rate. This mechanism of action makes it an effective positive inotropic agent, enhancing cardiac performance without relying on glycoside mechanisms.
Now, let's examine why the other options are incorrect:
A) Digoxin is a glycoside positive inotropic drug that works by inhibiting the sodium-potassium pump, leading to increased intracellular calcium levels and improved contractility. It is not a non-glycoside drug.
B) Strophantin K is a glycoside drug derived from the plant Strophanthus. Like digoxin, it acts by increasing intracellular calcium levels through sodium-potassium pump inhibition.
D) Digitoxin is another glycoside drug with a mechanism of action similar to digoxin and strophantin K, involving inhibition of the sodium-potassium pump.
Educationally, understanding the specific mechanisms of action of different drugs is essential for pharmacological management. Knowing the distinctions between glycoside and non-glycoside inotropic agents helps in selecting the most appropriate treatment based on the clinical scenario and patient characteristics. This knowledge is vital for healthcare professionals to make informed decisions and provide optimal care to patients.
Dobutamine works by stimulating beta-1 adrenergic receptors in the heart, leading to increased contractility and heart rate. This mechanism of action makes it an effective positive inotropic agent, enhancing cardiac performance without relying on glycoside mechanisms.
Now, let's examine why the other options are incorrect:
A) Digoxin is a glycoside positive inotropic drug that works by inhibiting the sodium-potassium pump, leading to increased intracellular calcium levels and improved contractility. It is not a non-glycoside drug.
B) Strophantin K is a glycoside drug derived from the plant Strophanthus. Like digoxin, it acts by increasing intracellular calcium levels through sodium-potassium pump inhibition.
D) Digitoxin is another glycoside drug with a mechanism of action similar to digoxin and strophantin K, involving inhibition of the sodium-potassium pump.
Educationally, understanding the specific mechanisms of action of different drugs is essential for pharmacological management. Knowing the distinctions between glycoside and non-glycoside inotropic agents helps in selecting the most appropriate treatment based on the clinical scenario and patient characteristics. This knowledge is vital for healthcare professionals to make informed decisions and provide optimal care to patients.